• Patient Care
• Education
• Research
• Community
• Referring Physicians
• Find a Physician
• Departments & Centers
• About Us

• Libraries
• Alumni
• Giving
• Home

URMC » Quality » Ratings » Heart Attack

Email this page

• Choose Us
• Commitment to Quality
• Quality Measures
  • Heart Attack
    • Overview
    • Aspirin on admission
    • Beta blocker on admission
    • Aspirin at discharge
    • Beta blocker at discharge
    • ACEI or ARB at discharge for patients with left ventricular systolic dysfunction
    • Smoking cessation
    • Availability of PTCA
    • Inpatient mortality for heart attacks
    • Length of stay for heart attack patients
    • Lipid-lowering therapy at discharge
    • Low-density lipoprotein (LDL) cholesterol assessment
  • Percutaneous Transluminal Coronary Angioplasty (PTCA)
  • Coronary Bypass Surgery (CABG)
  • Heart Failure
  • Pneumonia
  • Robotic Prostatectomy
  • Stroke
• Glossary of Terms

Quality Measures for Heart Attack

At Strong, specific steps, known as protocols, guide the care we provide to patients who have heart attacks. Our goal is to provide the best care and the greatest opportunities for recovery and return to health and normal activities, following a heart attack.

Strong’s team approach draws on the expertise of cardiologists, heart surgeons, cardiac catheter laboratory specialists, and vascular surgeons to ensure the best possible outcome for every patient.

As an example, Strong was the first hospital in Upstate New York to use the Arctic Sun non-invasive cooling system to reduce the risk of brain damage for some heart attack patients. With this system, a heart attack patient’s core temperature is lowered and closely monitored in the period immediately following the heart attack. Read more...

Leading the Way in Preventing Heart Attacks

Strong participates in cutting-edge research to improve the treatment of heart disease and reduce the risk of heart attacks. As an example, Strong is currently part of a study to test a drug called rimonabant and its effect on atherosclerosis, the build-up of cholesterol on the walls of arteries. Atherosclerosis is attributed to being a major cause of heart attack and stroke. Read more...

A device first implanted in the United States at the University of Rochester Medical Center is showing a significant reduction in blood pressure in patients who suffer from severe hypertension and cannot control their condition with medications or lifestyle changes. Early findings show promise for the safety and effectiveness of the Rheos™ Baroreflex Hypertension Therapy™ System, an implantable device for the treatment of hypertension in patients with drug-resistant hypertension. Read more...